OpenLegislation

Paragraph 2 Marketing authorizations

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Where a major application is made by a person who is already the holder of a clinical trial certificate in respect of a medicinal product containing the same active ingredient as the medicinal product in respect of which the marketing authorization is applied for, the fee payable under regulation 4(a) in connection with that application shall be reduced by the amount of the fee paid in connection with the application for that certificate.